Notice: Prescription Drug List (PDL): Hydrocortisone
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for hydrocortisone on the Prescription Drug List (PDL). Only the Human part of the PDL is to be revised; the listing for Veterinary use will remain unchanged.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Notice: Prescription Drug List (PDL): HydrocortisoneHTMLEnglish publication HTML
Notice: Prescription Drug List (PDL): HydrocortisoneHTMLFrench publication HTML